By Anna Greene, PhD, NETRF Director of Research  For many patients newly diagnosed with small, nonfunctioning pancreatic neuroendocrine tumors (PanNETs), active surveillance (AS) with regular imaging and monitoring may be recommended, especially when tumors are less than 2 cm in size, do not cause symptoms, and appear low-grade. But what if that approach sometimes isn’t … Continue reading When Watching Isn’t Enough: Somatostatin Analogs Show Promise in Small Pancreatic NETs